Literature DB >> 34177008

Rejoinder: Learning Optimal Distributionally Robust Individualized Treatment Rules.

Weibin Mo1, Zhengling Qi2, Yufeng Liu3.   

Abstract

We thank the opportunity offered by editors for this discussion and the discussants for their insightful comments and thoughtful contributions. We also want to congratulate Kallus (2020) for his inspiring work in improving the effciency of policy learning by retargeting. Motivated from the discussion in Dukes and Vansteelandt (2020), we first point out interesting connections and distinctions between our work and Kallus (2020) in Section 1. In particular, the assumptions and sources of variation for consideration in these two papers lead to different research problems with different scopes and focuses. In Section 2, following the discussions in Li et al. (2020); Liang and Zhao (2020), we also consider the efficient policy evaluation problem when we have some data from the testing distribution available at the training stage. We show that under the assumption that the sample sizes from training and testing are growing in the same order, efficient value function estimates can deliver competitive performance. We further show some connections of these estimates with existing literature. However, when the growth of testing sample size available for training is in a slower order, efficient value function estimates may not perform well anymore. In contrast, the requirement of the testing sample size for DRITR is not as strong as that of efficient policy evaluation using the combined data. Finally, we highlight the general applicability and usefulness of DRITR in Section 3.

Entities:  

Year:  2021        PMID: 34177008      PMCID: PMC8221610          DOI: 10.1080/01621459.2020.1866581

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  7 in total

1.  The use of propensity scores to assess the generalizability of results from randomized trials.

Authors:  Elizabeth A Stuart; Stephen R Cole; Catherine P Bradshaw; Philip J Leaf
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2001-04-01       Impact factor: 2.483

2.  Robustifying Trial-Derived Optimal Treatment Rules for A Target Population.

Authors:  Ying-Qi Zhao; Donglin Zeng; Catherine M Tangen; Michael L LeBlanc
Journal:  Electron J Stat       Date:  2019-04-30       Impact factor: 1.125

3.  Multiple robustness in factorized likelihood models.

Authors:  J Molina; A Rotnitzky; M Sued; J M Robins
Journal:  Biometrika       Date:  2017-06-15       Impact factor: 2.445

4.  Robust estimation of encouragement-design intervention effects transported across sites.

Authors:  Kara E Rudolph; Mark J van der Laan
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2016-10-31       Impact factor: 4.488

5.  Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.

Authors:  Ashley L Buchanan; Michael G Hudgens; Stephen R Cole; Katie R Mollan; Paul E Sax; Eric S Daar; Adaora A Adimora; Joseph J Eron; Michael J Mugavero
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2018-02-26       Impact factor: 2.483

6.  Toward Causally Interpretable Meta-analysis: Transporting Inferences from Multiple Randomized Trials to a New Target Population.

Authors:  Issa J Dahabreh; Lucia C Petito; Sarah E Robertson; Miguel A Hernán; Jon A Steingrimsson
Journal:  Epidemiology       Date:  2020-05       Impact factor: 4.860

7.  Veridical data science.

Authors:  Bin Yu; Karl Kumbier
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-13       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.